Peptides have taken over the world of biohacking. If you follow trends in body optimization, longevity, and rapid recovery, you've probably already heard them called “the molecules of the future.” And while many of them do have enormous therapeutic potential, there is a dangerous myth circulating in the biohacking space: that just because something is a peptide, it is automatically safe.
The truth is quite different. Biology does not work that way.
As responsible biohackers, our goal is not to blindly follow trends, but to make informed decisions grounded in science. In this article, we take off the rose-tinted glasses and examine the dark side of peptides — the clinical data behind dangerous synthetic fitness “supplements” such as Melanotan II, the deadliest peptide biotoxins in nature, and the toxic peptides our own bodies quietly produce.
Melanotan II: “The Barbie Drug”
Let's begin with what is most commonly found on the black market — the peptide Melanotan II. This peptide is a synthetic analog of the hormone alpha-melanocyte-stimulating hormone (α-MSH), and its function is to stimulate melanin production in the body, leading to skin darkening. Beyond this, Melanotan II is also known for increasing sexual arousal and promoting weight loss. It is not approved for human use by any official health authority, yet it is distributed illegally, often marketed under the name “The Barbie Drug.” Health authorities strongly warn against its use — let's look at why.
Systemic Toxicity and Rhabdomyolysis
In the article “Melanotan II injection resulting in systemic toxicity and rhabdomyolysis” (Nelson et al., 2012), the authors describe a clinical case of systemic toxicity and severe muscle damage following use of the compound. A 39-year-old man subcutaneously injected himself with Melanotan II in order to darken his skin during winter, reportedly taking a dose 6 times higher than the recommended one. Two hours after injection, the man was admitted to the emergency clinic with diffuse body pain, sweating, and severe anxiety. He was found to have high blood pressure, accelerated pulse, dilated pupils, and muscle tremors. Tests showed elevated creatinine and creatine kinase, confirming kidney dysfunction and rhabdomyolysis. The case highlights the serious risks of Melanotan II use: sympathomimetic toxicity, breakdown of muscle tissue, and impairment of kidney function.
Renal Infarction
Another clinical case is described in “Melanotan II: a possible cause of renal infarction: review of the literature and case report” — a 45-year-old, completely healthy man who was admitted to the hospital with symptoms of a renal crisis. The next day, the pain intensified, and a scan revealed a renal infarction that had already affected and damaged approximately 50% of his right kidney. After thorough cardiac and blood examinations, doctors categorically ruled out the usual causes (clotting problems, arrhythmia, or a thrombus from the heart). During his hospital stay, doctors noticed that the patient had a very strong, unnatural skin tan. Upon questioning, it became clear that for the past 6 months he had regularly been injecting Melanotan II, purchased illegally online, in order to tan. Laboratory analysis of the vial's residue confirmed the compound and found no other impurities.
Ischemic Priapism
Another dangerous side effect is discussed in “Melanotan Tanning Injection: A Rare Cause of Priapism” (Mallory et al., 2021) — the condition known as ischemic priapism. Priapism is a prolonged, very painful erection lasting for an extended time, unrelated to sexual stimulation. In the ischemic type, blood enters the penis but the veins are blocked, preventing it from returning to the body. The oxygen in this stagnant blood is rapidly depleted, leading to necrosis and fibrosis in the tissues and permanent impotence. The patient described had injected Melanotan II for 6 years without serious side effects, but was admitted emergently with priapism symptoms. Treatment proceeded according to standard procedures. Fifteen weeks later, however, the man had developed erectile dysfunction that did not respond even to standard erection pills. Doctors believe Melanotan II remains in the body for a long time, which prolonged the oxygen deprivation and irreversibly damaged the erectile tissue.
Oral Mucosa Pigmentation
Another side effect is pigmentation in the oral cavity. Usually, when a person stops injecting the compound, the skin tan fades and normalizes within about a month. However, in the case described in “Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report” (Bonchev, 2026), the spots in the patient's mouth had not disappeared even 3 months after the injections ceased. While the article does not state this directly, it warns that there are documented cases in the medical literature of skin cancer associated with its use.
GHRPs and IGF-1 LR3: Hacking the Metabolic Engine
If Melanotan II represents a risky attempt to hack our “packaging” — chasing a quick cosmetic effect at the cost of chaos in the nervous system — then the next group of peptides goes much deeper. They reach directly into the “engine” of our metabolism. Setting aside the vanity of tanning, we now enter the territory of physical performance and longevity. Growth hormone secretagogues (GHRPs) and IGF-1 LR3 — molecules that promise superhuman recovery but quietly rewrite the rules of cellular growth in your body, often with fatal consequences.
GHRPs are synthetic molecules that mimic the hunger hormone (ghrelin). They send a powerful signal to the pituitary gland to produce and release huge amounts of human growth hormone (HGH). Chronically high levels of growth hormone (induced by GHRPs), however, cause the liver to produce more glucose and block the action of insulin.
The Insulin–Growth Hormone Antagonism
To understand the process, we need to know that insulin is the hormone that helps cells “absorb” sugar from the blood (i.e., lowers it). Growth hormone, a so-called “counter-regulatory hormone,” does the exact opposite. Its main role in human evolution has been to protect the brain and body from hypoglycemia during fasting, by maintaining or raising blood glucose — the so-called diabetogenic effect.
How? The hormone stimulates the liver and kidneys to actively produce new glucose and release it directly into the bloodstream. In parallel, it has a strong influence on adipose tissue — preventing fat cells from absorbing sugar and simultaneously inducing lipolysis (a process of intense fat breakdown). The hormone causes fat cells to “melt” and dump fats into the bloodstream. As a result, large amounts of free fatty acids (FFAs) are released. When their concentration becomes excessive, they begin to interfere with the liver's and muscles' ability to recognize and respond adequately to insulin signals.
Enter IGF-1
Now add the complicating factor, IGF-1. Growth hormone stimulates the liver to produce another very important element — Insulin-like Growth Factor 1. IGF-1 acts very similarly to insulin itself and lowers blood sugar. For this reason, the final effect of growth hormone in the body is a complex balance between its own (sugar-raising) action and the (sugar-lowering) action of IGF-1. While growth hormone runs through the streets raising sugar and clogging the cellular locks with fats, its assistant IGF-1 acts as a master key — attempting by any means to unlock the cell doors so the sugar from the streets can be brought inside (S. Kim & Park, 2017).
The Risks of Exogenous Growth Hormone
The main risk of taking exogenous growth hormone is a drastic reduction in tissue sensitivity to insulin. The hormone actively blocks insulin's action in muscle and adipose tissue. This forces the body to produce ever larger amounts of insulin (hyperinsulinemia) to keep blood sugar within normal range. Prolonged exposure to high hormone levels can exhaust the pancreas and lead to the development of type 2 diabetes.
Another dangerous risk is the flip side of the desired fat-burning effect — science warns about the reverse: this process floods the bloodstream with free fatty acids. Excessive levels of these acids act as a metabolic barrier — they accumulate in muscle cells as lipid intermediates that literally clog the cellular pathways through which insulin transports glucose.
Other dangerous side effects include disruption of hepatic glucose production and the risks of high doses. Growth hormone sends incorrect signals to the liver and kidneys, stimulating them to produce new sugar (gluconeogenesis) even when the body has no need for it. The result is persistently elevated fasting blood glucose — an early marker of metabolic collapse. Studies show that while low, physiological doses under medical supervision may have benefits in cases of deficiency, high doses (often used in biohacking circles) invariably lead to worsening glucose tolerance. Even in healthy people, short-term use of high doses can rapidly induce a state resembling prediabetes (S. Kim & Park, 2017).
Amatoxins: Nature's Deadliest Peptides
Among the natural peptide biotoxins that nature has created are the amatoxins. These are cyclic peptides found in highly poisonous mushrooms such as Amanita phalloides (the death cap). They are so dangerous because they inhibit the enzyme RNA polymerase II (Bushnell et al., 2002). This literally halts protein synthesis in cells and leads to fatal hepatic and renal failure (Garcia et al., 2015). To understand how powerful these peptides are, it suffices to look at modern science. According to research published in the Journal of the National Cancer Institute, the only medical application of amatoxins today is in experimental ADC therapies (Antibody-Drug Conjugates) — where scientists use their merciless toxicity as a sniper targeted exclusively at cancer cells (Moldenhauer et al., 2012).
Blue-Green Algae: The Hidden Contamination
Blue-green algae are known for their effects in boosting energy and mood. However, their risks have long been overlooked in the context of dietary supplement ingredients. Most of these products contain the alga Aphanizomenon flos-aquae, harvested from Upper Klamath Lake in Oregon, USA. In that same lake, however, another highly toxic species of algae regularly blooms — Microcystis aeruginosa. The toxic species produces compounds called microcystins, which are potent hepatotoxins (liver-damaging) and probable tumor promoters. During the harvesting of the beneficial algae, the toxic ones often end up in the nets unintentionally, leading to contamination of the final product. After 1996, health authorities established a permitted limit of 1 microgram per gram for microcystins in supplements. In testing, however, the results are often alarming (Gilroy et al., 2000).
The researchers behind the article “Toxin content and cytotoxicity of algal dietary supplements” (Heussner et al., 2012) analyzed 13 different products containing Spirulina, Aphanizomenon flos-aquae, and Chlorella — as well as their mixtures — for the presence of several types of toxins (microcystins, nodularins, saxitoxins, anatoxin-a, and cylindrospermopsin) through various laboratory methods. They also tested the effect of the extracts on human lung cells (A549) to determine whether they killed the cells. The most concerning finding was that extracts from all tested products showed a cytotoxic effect — i.e., they were toxic and damaging to the human cells studied.
Amyloid-Beta: The Peptide We Produce Ourselves
The dark side of peptides does not come only from illegal labs or poisonous algae. Sometimes the most dangerous peptide is produced inside us. This is amyloid-beta — a peptide (Aβ) that our brain generates daily. It is derived from a larger molecule called amyloid precursor protein (APP). In a healthy organism, APP is processed by an enzyme called secretase, which “cuts” it in a manner that prevents the formation of harmful amyloid. There also exists, however, an alternative metabolic pathway that passes through cellular lysosomes. In this pathway, intact fragments are generated containing the entire Aβ sequence. These fragments have the ability to precipitate and form insoluble extracellular deposits known as amyloid plaques between the synapses of neurons.
Synapses are the connection through which neurons communicate. To learn something new, these connections must strengthen. To forget something unnecessary — they weaken. The accumulation of amyloid plaques, however, prevents brain cells from forming strong connections when we learn something new — they artificially cause cells to weaken and sever pre-existing connections, literally causing the small “plugs” of brain cells to disappear, breaking the physical communication between them. To confirm their finding, scientists (Shankar et al., 2008) took these small, floating protein dimers directly from the brains of people who had died from Alzheimer's and injected them into completely healthy rats. The result? The rats almost immediately began to forget things they had just learned.
According to a landmark study in Science, when you fall asleep, the space between your brain cells increases by 60%. This expansion allows cerebrospinal fluid to rush in like water under pressure and wash away the neurotoxins generated by the brain's daytime activity. The most important waste being cleared is beta-amyloid — the protein responsible for brain fog and the development of Alzheimer's (Xie et al., 2013).
References
- Nelson, M. E., Bryant, S. M., & Aks, S. E. (2012). Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clinical Toxicology, 50(10), 1169–1173. https://doi.org/10.3109/15563650.2012.740637
- Peters, B., Hadimeri, H., Wahlberg, R., & Afghahi, H. (2020). Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Reports, 9(2), 159–161. https://doi.org/10.1007/s13730-020-00447-z
- Mallory, C. W., Lopategui, D. M., & Cordon, B. H. (2021). Melanotan tanning injection: a rare cause of priapism. Sexual Medicine, 9(1), 100298. https://doi.org/10.1016/j.esxm.2020.100298
- Kim, S., & Park, M. (2017). Effects of growth hormone on glucose metabolism and insulin resistance in human. Annals of Pediatric Endocrinology & Metabolism, 22(3), 145–152. https://doi.org/10.6065/apem.2017.22.3.145
- Bushnell, D. A., Cramer, P., & Kornberg, R. D. (2002). Structural basis of transcription: α-Amanitin–RNA polymerase II cocrystal at 2.8 Å resolution. Proceedings of the National Academy of Sciences, 99(3), 1218–1222. https://doi.org/10.1073/pnas.251664698
- Garcia, J., Costa, V. M., Carvalho, A., Baptista, P., De Pinho, P. G., De Lourdes Bastos, M., & Carvalho, F. (2015). Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food and Chemical Toxicology, 86, 41–55. https://doi.org/10.1016/j.fct.2015.09.008
- Moldenhauer, G., Salnikov, A. V., Lüttgau, S., Herr, I., Anderl, J., & Faulstich, H. (2012). Therapeutic potential of Amanitin-Conjugated Anti-Epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma. JNCI Journal of the National Cancer Institute, 104(8), 622–634. https://doi.org/10.1093/jnci/djs140
- Gilroy, D. J., Kauffman, K. W., Hall, R. A., Huang, X., & Chu, F. S. (2000). Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements. Environmental Health Perspectives, 108(5), 435–439. https://doi.org/10.1289/ehp.00108435
- Heussner, A., Mazija, L., Fastner, J., & Dietrich. (2012). Toxin content and cytotoxicity of algal dietary supplements. Toxicology and Applied Pharmacology, 265(2), 263–271. https://doi.org/10.1016/j.taap.2012.10.005
- Hardy, J. A., & Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science, 256(5054), 184–185.
- Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., Regan, C. M., Walsh, D. M., Sabatini, B. L., & Selkoe, D. J. (2008). Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine, 14(8), 837–842. https://doi.org/10.1038/nm1782
- Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O'Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., & Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. https://doi.org/10.1126/science.1241224
- Bonchev, A. (2026). Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. Life, 16(2), 265. https://doi.org/10.3390/life16020265